How Buprenorphine Access Will Affect Pharmacists
Buprenorphine Legislation: From the X Waiver to the MAT Act The Drug Addiction Treatment Act of 2000 waiver, also known as the DEA X-waiver, allowed clinicians to prescribe buprenorphine, a controlled substance medication, to treat opioid dependency. Established in 2000, the law required physicians to undergo specific training and register with Drug Enforcement Administration (DEA) […]
Read More ›Protecting Public Health through Accreditations and Inspections
NABP is proud to offer accreditation and inspection programs for pharmacies, drug distributors, and medical device distributors. In the role of Compliance Senior Manager, Accreditation and Inspection Programs, Betty Jones tackles complex compliance issues to keep patients safe around the nation. In this blog, she shares stories from her career and how the NABP accreditation […]
Read More ›The Changing Pharmacy Landscape and its Effects on Patient Safety
Though the coronavirus disease 2019 (COVID-19) public health emergency declarations have officially come to an end, the effect of the pandemic and changes to professional roles and workplace standards will be felt by pharmacists and workers across many industries for years to come. In the post-COVID-19 context, the pharmacy landscape continues to evolve. Noteworthy demographic […]
Read More ›Supporting Mental Health and Well-Being for Pharmacists and Pharmacy Staff
Over the past several years, the pharmacy profession has seen concerning rates of burnout in this era’s so-called “Great Resignation.” Pharmacists and pharmacy technicians have raised concerns over a lack of work-life balance, long hours, and understaffing because these issues have led to unsafe work conditions and, ultimately, pose a threat to patient safety. Along […]
Read More ›Rise of Digital Pharmacy: How Emerging Technologies Are Changing the Practice
Change has been a near-constant companion to pharmacists and pharmacy regulators over the last decade, with many of those changes accelerated by the coronavirus disease 2019 pandemic. As pharmacist duties and responsibilities have increased, many have experienced greater demand for their services. The resulting strain has made well-being and burnout one of the most concerning […]
Read More ›Lifelong Learning in the Role of a Pharmacy Inspector
Careers in pharmacy involve lifelong learning and adaptation to new situations. In this feature, a Virginia pharmacy inspector discusses her ever-changing role in the field. Amy Branson, PharmD, RPh Pharmacy Inspector, Virginia Department of Health Professions How long have you been serving as a pharmacy inspector for the Board? What was your prior role? I […]
Read More ›How Trading Partners Can Prepare for DSCSA
As the DSCSA interoperability deadline approaches, we at NABP remain focused on critical Drug Supply Chain Security Act (DSCSA) infrastructure and committed to helping align all sectors of the supply chain that support and provide safe medication to patients in the United States. This is the fourth blog of a series that explores steps we […]
Read More ›Promoting Pharmacist Well-Being and Patient Safety with Just Culture Approach
In high-stakes environments such as pharmacies, where dangerous or even deadly medication errors can occur, the need for a culture of safety has become increasingly apparent. At the same time, burnout and working conditions are causing many pharmacists and technicians to leave the profession at an alarming rate, contributing to a shortage of qualified pharmacy […]
Read More ›How the Industry Can Enable a Realistic Adoption to DSCSA Compliance
As the DSCSA interoperability deadline approaches, we at NABP remain focused on critical Drug Supply Chain Security Act (DSCSA) infrastructure and committed to helping align all sectors of the supply chain that support and provide safe medication to patients in the United States. This is the third blog of a series that explores steps we […]
Read More ›NABP Supports a Flexible Approach to DSCSA Digital Credentials
As the DSCSA interoperability deadline approaches, we at NABP remain focused on critical Drug Supply Chain Security Act (DSCSA) infrastructure and committed to helping align all sectors of the supply chain that support and provide safe medication to patients in the United States. This is the second blog of a series that explores steps we […]
Read More ›